Plasenta Previa Perkreata Tanı ve Yönetimi: Olgu Sunumu

Cem Yener; Cenk Sayın; Füsun Varol

Case Report

Plasenta Previa Perkreata Tanı ve Yönetimi: Olgu Sunumu

Year 2018, Volume: 6 Issue: 3, 117 - 121, 13.12.2018

Abstract

Plasenta perkreata, sezaryen ile
doğum ve diğer uterin girişimlerdeki artış ile beraber olarak son yıllarda daha
yaygın görünür hale gelmiştir. Gebelik esnasındaki doğru tanının çok büyük
önemi vardır. Doğru yönetilen hastalarda morbidite ve mortalite oranları daha
düşüktür. Bu olgu sunumunda perinatoloji kliniğimize yönlendirilen bir plasenta
perkreata olgusunun yönetimini sunmaktayız.

Keywords

Hemoraji, plasenta perkreta, histerektomi, mesane yaralanması, transfüzyon

References

1. Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previa – placenta acreta. Am J Obstet Gynecol 1997;177:210-214.
2. Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty year analysis. Am J Obstet Gynecol 2005; 192: 1458-61.
3. Jennifer L. Bailit, M.D., M.P.H.1, William Grobman, M.D., M.B.A.2, Madeline Murguia Rice,Ph.D.3, Uma M. Reddy, M.D., M.P.H.4, Ronald J. Wapner, M.D.5, Michael W. Varner, M.D.6,Kenneth J. Leveno, M.D.7, Jay D. Iams, M.D.8, Alan T. N. Tita, M.D. Ph.D.9, George Saade,M.D.10, Dwight J. Rouse, M.D.11, Sean C. Blackwell, M.D.12, and the Eunice Kennedy. Morbidly Adherent Placenta Treatments and Outcomes
4. Silver RM, Landon MB, Rouse DJ, et al: Maternal morbidty associated with multiple cesarean deliveries. Obstet Gyncol 107:1226, 2006
5. Comstock CH, Love JJ Jr, Bronsteen RA, Lee W, Vettraino IM, Huang RR, et al. Sonographic detection of placenta accreta in the second and third trimesters of pregnancy. Am J Obstet Gynecol 2004; 190: 1135-40.
6. Lax A, Prince M, Mennitt KW, Schwebach JR, Budorick NE. The value of specific MRI features in the evaluation of suspected placental invasion. Magnetic ResonanceI maging 2007; 25: 87-93.
7. Chalubinski KM, Pils S, Klein K, Seemann R, Speiser P, Langer M, Ott J. Prenatal sonography can predict degree of placental invasion. Ultrasound Obstet Gynecol 2013; 42: 518-524.
8. Michael A. Belfort, MBBCH, DA (SA), MD, PhD, FRCOG, FACOGa,b,c,d,n, Alireza A. Shamshirsaz, MD, FACOGe, and Karin A. Fox, MD, MEd, FACOGe ; The diagnosis and management of morbidly adherent placenta
9. Committee on Obstetric Practice. ACOG committee opinion. Placenta accreta. Int J Gynaecol Obstet 2002; 77: 77-8.
10. Kupferminc MJ, tAMURA RK , Wigton TR, et al : Placenta accreta is associated with elevated maternal serum alpha-fetoprotein. Obstet Gynecol 82:266, 1993.
11. Perez-Delboy A, Wright JD. Surgical management of placenta accreta: tole aveorre move the placenta? BJOG 2014;121:163–170.
12. Price F.V., Resnik E., Heller K.A., Christopherson W.A. Placenta previa percreta involving the urinary bladder: a report of two cases and review of the literature. Obstet Gynecol. 1991;78(3 Pt 2):508–511.[PubMed]
13. Abbas F., Talati J., Wasti S. Placenta percreta with bladder invasion as a cause for life threatening hemorrhage. J Urol. 2000;164:1270–1274. [PubMed]
14. Takai N., Eto M., Sato F. Placenta percreta invading the urinary bladder. Arch Gynecol Obstet. 2005;271:274–275. [PubMed]
15. Serkan Kahyaoğlu*, Şevki Çelen, İnci Kahyaoğlu, Leyla Mollamahmutoğlu, Nuri Danışman; Morbidly adherent placenta: Clinical approach and management16. Einerson BD, Rodriguez CE, Kennedy AM, Woodward PJ, Donnelly MA, Silver RM.Magnetic resonance imaging is often misleading when used as an adjunct toultrasound in the management of placenta accreta spectrum disorders. Am J Obstet Gynecol. 2018 Mar 20.
17. Buca D, Liberati M, Calì G, Forlani F, Caisutti C, Flacco ME, Manzoli L,Familiari A, Scambia G, D'Antonio F. Influence of prenatal diagnosis ofabnormally invasive placenta on maternal outcome: a systematic review andmeta-analysis. Ultrasound Obstet Gynecol. 2018 Apr 16.
18. Rolná M, Matlák P, Dvořáčková J. [Placenta percreta as a cause of massiveintraabdominal bleeding]. Ceska Gynekol. 2017 Winter;82(6):478-481. Czech. PubMed
19. The urologist’s role in multidisciplinarymanagement of placenta percreta. Briony L. Norris*, Wouter Everaerts*, Elske Posma†, Declan G. Murphy*,‡, Mark P.Umstad†,§, Anthony J. Costello*, C. David Wrede†,§and Jamie Kearsley

Year 2018, Volume: 6 Issue: 3, 117 - 121, 13.12.2018

Cem Yener , Cenk Sayın Füsun Varol

Abstract

References

1. Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previa – placenta acreta. Am J Obstet Gynecol 1997;177:210-214.
2. Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty year analysis. Am J Obstet Gynecol 2005; 192: 1458-61.
3. Jennifer L. Bailit, M.D., M.P.H.1, William Grobman, M.D., M.B.A.2, Madeline Murguia Rice,Ph.D.3, Uma M. Reddy, M.D., M.P.H.4, Ronald J. Wapner, M.D.5, Michael W. Varner, M.D.6,Kenneth J. Leveno, M.D.7, Jay D. Iams, M.D.8, Alan T. N. Tita, M.D. Ph.D.9, George Saade,M.D.10, Dwight J. Rouse, M.D.11, Sean C. Blackwell, M.D.12, and the Eunice Kennedy. Morbidly Adherent Placenta Treatments and Outcomes
4. Silver RM, Landon MB, Rouse DJ, et al: Maternal morbidty associated with multiple cesarean deliveries. Obstet Gyncol 107:1226, 2006
5. Comstock CH, Love JJ Jr, Bronsteen RA, Lee W, Vettraino IM, Huang RR, et al. Sonographic detection of placenta accreta in the second and third trimesters of pregnancy. Am J Obstet Gynecol 2004; 190: 1135-40.
6. Lax A, Prince M, Mennitt KW, Schwebach JR, Budorick NE. The value of specific MRI features in the evaluation of suspected placental invasion. Magnetic ResonanceI maging 2007; 25: 87-93.
7. Chalubinski KM, Pils S, Klein K, Seemann R, Speiser P, Langer M, Ott J. Prenatal sonography can predict degree of placental invasion. Ultrasound Obstet Gynecol 2013; 42: 518-524.
8. Michael A. Belfort, MBBCH, DA (SA), MD, PhD, FRCOG, FACOGa,b,c,d,n, Alireza A. Shamshirsaz, MD, FACOGe, and Karin A. Fox, MD, MEd, FACOGe ; The diagnosis and management of morbidly adherent placenta
9. Committee on Obstetric Practice. ACOG committee opinion. Placenta accreta. Int J Gynaecol Obstet 2002; 77: 77-8.
10. Kupferminc MJ, tAMURA RK , Wigton TR, et al : Placenta accreta is associated with elevated maternal serum alpha-fetoprotein. Obstet Gynecol 82:266, 1993.
11. Perez-Delboy A, Wright JD. Surgical management of placenta accreta: tole aveorre move the placenta? BJOG 2014;121:163–170.
12. Price F.V., Resnik E., Heller K.A., Christopherson W.A. Placenta previa percreta involving the urinary bladder: a report of two cases and review of the literature. Obstet Gynecol. 1991;78(3 Pt 2):508–511.[PubMed]
13. Abbas F., Talati J., Wasti S. Placenta percreta with bladder invasion as a cause for life threatening hemorrhage. J Urol. 2000;164:1270–1274. [PubMed]
14. Takai N., Eto M., Sato F. Placenta percreta invading the urinary bladder. Arch Gynecol Obstet. 2005;271:274–275. [PubMed]
15. Serkan Kahyaoğlu*, Şevki Çelen, İnci Kahyaoğlu, Leyla Mollamahmutoğlu, Nuri Danışman; Morbidly adherent placenta: Clinical approach and management16. Einerson BD, Rodriguez CE, Kennedy AM, Woodward PJ, Donnelly MA, Silver RM.Magnetic resonance imaging is often misleading when used as an adjunct toultrasound in the management of placenta accreta spectrum disorders. Am J Obstet Gynecol. 2018 Mar 20.
17. Buca D, Liberati M, Calì G, Forlani F, Caisutti C, Flacco ME, Manzoli L,Familiari A, Scambia G, D'Antonio F. Influence of prenatal diagnosis ofabnormally invasive placenta on maternal outcome: a systematic review andmeta-analysis. Ultrasound Obstet Gynecol. 2018 Apr 16.
18. Rolná M, Matlák P, Dvořáčková J. [Placenta percreta as a cause of massiveintraabdominal bleeding]. Ceska Gynekol. 2017 Winter;82(6):478-481. Czech. PubMed
19. The urologist’s role in multidisciplinarymanagement of placenta percreta. Briony L. Norris*, Wouter Everaerts*, Elske Posma†, Declan G. Murphy*,‡, Mark P.Umstad†,§, Anthony J. Costello*, C. David Wrede†,§and Jamie Kearsley

There are 18 citations in total.

Details

Primary Language	Turkish
Journal Section	Case Report
Authors	Cem Yener Cenk Sayın This is me Füsun Varol
Publication Date	December 13, 2018
Published in Issue	Year 2018 Volume: 6 Issue: 3

Cite

APA	Yener, C., Sayın, C., & Varol, F. (2018). Plasenta Previa Perkreata Tanı ve Yönetimi: Olgu Sunumu. Namık Kemal Tıp Dergisi, 6(3), 117-121.
AMA	Yener C, Sayın C, Varol F. Plasenta Previa Perkreata Tanı ve Yönetimi: Olgu Sunumu. NKMJ. December 2018;6(3):117-121.
Chicago	Yener, Cem, Cenk Sayın, and Füsun Varol. “Plasenta Previa Perkreata Tanı Ve Yönetimi: Olgu Sunumu”. Namık Kemal Tıp Dergisi 6, no. 3 (December 2018): 117-21.
EndNote	Yener C, Sayın C, Varol F (December 1, 2018) Plasenta Previa Perkreata Tanı ve Yönetimi: Olgu Sunumu. Namık Kemal Tıp Dergisi 6 3 117–121.
IEEE	C. Yener, C. Sayın, and F. Varol, “Plasenta Previa Perkreata Tanı ve Yönetimi: Olgu Sunumu”, NKMJ, vol. 6, no. 3, pp. 117–121, 2018.
ISNAD	Yener, Cem et al. “Plasenta Previa Perkreata Tanı Ve Yönetimi: Olgu Sunumu”. Namık Kemal Tıp Dergisi 6/3 (December 2018), 117-121.
JAMA	Yener C, Sayın C, Varol F. Plasenta Previa Perkreata Tanı ve Yönetimi: Olgu Sunumu. NKMJ. 2018;6:117–121.
MLA	Yener, Cem et al. “Plasenta Previa Perkreata Tanı Ve Yönetimi: Olgu Sunumu”. Namık Kemal Tıp Dergisi, vol. 6, no. 3, 2018, pp. 117-21.
Vancouver	Yener C, Sayın C, Varol F. Plasenta Previa Perkreata Tanı ve Yönetimi: Olgu Sunumu. NKMJ. 2018;6(3):117-21.